🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

82+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 82 recruiting trials for “aggressive-systemic-mastocytosis

Phase 1RecruitingNCT06925542

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

🏥 CRISPR Therapeutics📍 8 sites📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06822881

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

🏥 Beijing GoBroad Hospital📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06843239

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

👨‍⚕️ Study Director, Zura Bio Inc📍 51 sites📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06375005

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

👨‍⚕️ JING XUE, PhD, Second Affiliated Hospital, School of Medicine, Zhejiang University📍 9 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT05879146

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

👨‍⚕️ Keila Torres, MD,PHD, M.D. Anderson Cancer Center📍 1 site📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06472362

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

👨‍⚕️ Elisabetta A Renzoni, Royal Brompton and Harefield Hospitals📍 7 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06655896

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 80 sites📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06658483

Hand ScleroDerma Lived Experience Scale in Individuals With Systemic Sclerosis

🏥 Pamukkale University📍 2 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06182293

Periodontal Microbiota in Systemic Sclerosis

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06660121

Electrochemotherapy for Desmoid Tumors

👨‍⚕️ Giancarlo Facchini, Medicine and Surgery, IRCCS Istituto Ortopedico Rizzoli📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06470048

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 127 sites📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06646913

TENS in Scleroderma

🏥 University of Michigan📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT05785065

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

👨‍⚕️ Sabrina Hoa, MD, Centre hospitalier de l'Université de Montréal (CHUM)📍 3 sites📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06328777

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

👨‍⚕️ Medical Director, Cabaletta Bio📍 10 sites📅 Started Jul 2024View details ↗
RecruitingNCT06598982

Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis

🏥 Selcuk University📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06474910

Connective Tissue Massage in Scleroderma

🏥 Firat University📍 1 site📅 Started Jun 2024View details ↗
Phase 1RecruitingNCT06414135

Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis

👨‍⚕️ Liangjing Lu, RenJi Hospital📍 1 site📅 Started Jun 2024View details ↗
Phase 4RecruitingNCT06546540

The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis

🏥 Peking University Third Hospital📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT07012655

Color Doppler Ultrasonography Evaluation of Abdominal and Peripheral Vasculopathy in Systemic Sclerosis Patients

👨‍⚕️ Sara Farrag, Lecturer, Assiut University📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06133244

Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)

🏥 UMC Utrecht📍 1 site📅 Started Apr 2024View details ↗
← PreviousPage 2 of 5Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →